The three class I alcohol dehydrogenases (ADHs) in humans comprise homo-and heterodimers of three subunits (␣, ␤, and ␥) with greater than 90% sequence identity. These are encoded by distinct genes (ADH1, ADH2, and ADH3, respectively) and are all expressed in the liver. In baboons, only the ␤ADH subunit is expressed in liver. A second class I ADH is expressed in the kidney; we isolated, cloned, and sequenced the cDNA corresponding to this ADH and conclude that it is of the ␥ADH lineage. We also amplified and sequenced the 5Ј noncoding regions of all three class I baboon ADH genes and the rhesus monkey ADH1 gene and compared their nucleotide sequences with the corresponding human sequences. There is clear evidence that the evolution of these genes has been reticulate. At least three gene conversion events, affecting the coding and 3Ј noncoding regions of the genes, are inferred from compatibility and partition matrices and phylogenetic analysis of the sequences. Our estimation of the evolutionary history of these genes provides a framework for the investigation of relative substitution rates and functional variation among the sequences. Relative-rate tests, designed to account for the reticulate evolution of these genes, indicate no difference in substitution rate either between genes encoding different subunits or between human and Old World monkey lineages. The human and baboon ␥ADH sequences do not show clear differences at functionally important sites within the coding region, but they do differ at a number of sites in regions previously proposed to be regulatory sites for transcriptional control. This variation may explain the different patterns of gene expression in humans and baboons.
Introduction
Mammalian alcohol dehydrogenases (ADHs; alcohol: NADϩ oxido-reductase; EC 1.1.1.1) are dimeric zinc-metalloenzymes which catalyze the reversible oxidation of alcohols to aldehydes or ketones. Human (Homo sapiens) ADHs exist as a family of enzymes which has been subdivided into at least five classes (designated I-V) based on distinctive kinetic and immunological properties and on structural similarities of encoded cDNAs and protein subunits (Edenberg 1991; Yasunami, Chen, and Yoshida 1991; Pares et al. 1992; Stone et al. 1993) . Comparisons between the classes show at least 60% positional identity with each other.
Human class I ADHs exhibit further multiplicity, comprising homo-and heterodimers of three highly similar (Ͼ90%) subunits ␣, ␤, and ␥, which are encoded by distinct genes (ADH1, ADH2, and ADH3, respectively; Edenberg and Brown 1992; Holmes 1993) . These class I enzymes are all expressed in the adult human liver. However, they are differentially distributed in other tissues of the body (Smith, Hopkinson, and Harris 1971) , being subject to distinct regulatory signals during development; for example, ADH2 is expressed in the human kidney, and ADH3 is expressed in the human stomach. A number of cis-acting regulatory sites have been identified in the 5Ј regions of the human class I ADH genes, which presumably contribute to the differential expression observed (Deuster 1991; Edenberg and Brown 1992) .
It is not clear why three highly similar class I isozymes exist. It is possible that the small number of amino acid differences between them results in important kinetic differences that are related to their role in the particular tissue in which they are expressed. Alternatively, the existence of multiple genes may be a device that facilitates differential expression in different tissues and at different times during development by allowing a diversity of cis-acting regulatory elements to associate with very similar coding sequences.
The baboon (Papio hamadryas) genome also contains three class I ADH genes (Trezise et al. 1989 (Trezise et al. , 1991 , but their pattern of expression is quite different. Whereas all three class I isozymes are expressed in the human liver, only one isozyme, ␤ADH, is expressed in the baboon liver (Holmes, Courtney, and Vandeberg 1986 ; see also Trezise et al. 1989 Trezise et al. , 1991 . A second class I isozyme is expressed in the baboon kidney (Holmes, Meyer, and Vandeberg 1990) , but no additional isozymes have been observed in kidney or other baboon tissues (Holmes, Courtney, and Vandeberg 1986) . The different expression patterns in these relatively closely related taxa make the class I ADHs a useful model for investigating the evolution of gene regulation in multigene families. Such investigation must, however, be based on a sound understanding of the gene phylogeny.
Three models have been proposed for the evolution of primate class I ADH genes (Ikuta, Szeto, and Yoshida 1986; Yokoyama and Yokoyama 1987; Yokoyama et al. 1990; Trezise et al. 1991; Sun and Plapp 1992; Yokoyama and Harry 1993) . These all involve successive duplications from a single ''proto-primate'' ancestral ADH gene, generating the three class I ADH genes now present in humans and Old World monkeys. They differ, however, in the order and timing of gene duplication events, and none of the analyses has clearly resolved the gene phylogeny.
Here, we further investigate the difference in expression pattern between human and baboons by determining which class I ADH gene (and hence which isozyme) is expressed in the baboon kidney. We also investigate the evolutionary history of all three class I ADH genes of both humans and Old World monkeys. Our comparative sequence analysis provides a basis for understanding the molecular mechanisms underlying the different expression patterns of the class I ADH genes.
Materials and Methods
Preparation of RNA Frozen kidney tissue was homogenized by using 30-s bursts of an Ultra-Turrax homogenizer in 8 volumes of a 1:1 mixture of buffer (20 mM Tris-HCl, pH 8.6; 10 mM NaCl)-saturated phenol and the same buffer containing 3 mM magnesium acetate and 5% sucrose (Berger and Birkenmeier 1979; Noyes et al. 1979) . The homogenate was extracted twice with buffer-saturated phenol and once with buffer-saturated phenol/chloroform/isoamyl alcohol, 25:24:1 (vol/vol/vol), and the nucleic acids were precipitated with ethanol. The RNA was then precipitated with LiCl (Weinberg, Warnaar, and Winocaur 1972) , extracted with phenol again, and, finally, precipitated with ethanol. Poly Aϩ RNA was isolated using biotinylated oligo(dT) (Promega Corp., USA).
cDNA Synthesis and Cloning cDNA was synthesized using a modified reverse transcriptase (Gibco-BRL), using 2-g mRNA with an oligo(dT) primer. The reaction was diluted to 1 ml, and 10 l of the mix was used in the PCR. Bab081, Bab091, and Bab11 primers (table 1) were designed from the baboon ␤ADH sequence (Trezise et al. 1989) . Thus, Bab081 and Bab091 were used to amplify a 295-bp fragment. The primer Bab10 was designed using sequence information from this fragment and, with Bab11, amplified an overlapping 614 bp. The primer Bab12 was designed, in turn, using sequence information from this fragment. Amplification of the 3Ј end was accomplished using cDNA synthesized from the RACE primer (Frohman, Dush, and Martin 1988) , with Bab12 and RACE-2 as the PCR primers. Amplifications were performed using Taq polymerase (Promega Corp.), using the buffer supplied, for 35 cycles with an annealing temperature of 55ЊC or 63ЊC.
PCR products were cloned using restriction sites which were within the 5Ј ends of each primer into pBluescript pSKϩ (Stratagene). Recombinant clones were determined using color selection on MacConkey agar (Jennings and Beacham 1989) . Plasmid DNA was denatured with NaOH and sequenced on both strands using a modified T7 DNA polymerase (USB). The sequence was derived from three independent amplifications.
5Ј ADH Nucleotide Sequences from Baboon and Rhesus Specific 5Ј upstream primers (BAB A and BAB C; table 1) were constructed against the human ADH1 and ADH3 gene sequences (Stewart et al. 1990 ), respectively, to enable the amplification of the corresponding baboon ADH and rhesus (Macaca mulatta) ADH1 gene sequences from genomic DNA, which was prepared as previously described (Trezise et al. 1991) . BAB A, when compared with the corresponding human ADH2 and ADH3 sequences, has only 2 and 3 nucleotides in common, respectively; likewise, when compared with the corresponding human ADH1 or ADH2 sequence, BAB C has only one nucleotide in common. The downstream primers for the ADH1 (␣ subunit) and ADH3 (␥ subunit) genes were Bab04 and Bab06, respectively (see table 1 ). Amplification was achieved after 35 cycles using a 63ЊC annealing temperature. Sequences were determined on an automated DNA sequencer, using fluorescent dideoxy terminators, after subcloning with appropriate restriction enzymes in the case of the baboon sequences; the sequence was derived from three independent amplifications. In the case of the rhesus sequence, the PCR product was directly sequenced.
Sequence Analysis
Coding and noncoding sequences of the human (Hempel et al. 1984 (Hempel et al. , 1985 von Bahr-Lindstrom et al. 1986; Hoog et al. 1986 ), baboon (Trezise et al. 1989) , and rhesus monkey (Light et al. 1992) class I ADH genes were aligned using CLUSTAL W (Thompson, Higgins, and Gibson 1994) through the Australian National Genome Information Service (ANGIS), with minor adjustments made by eye using Genetic Data Environment (GDE), version 2 (Smith et al. 1994 ). The alignment is available on the World Wide Web at http://jcsmr.anu.edu/dmm/humgen.html. The DDBJ/ EMBL/GenBank accession numbers for the compared sequences (coding/3Ј noncoding and 5Ј noncoding) are: ADH1-M12963 and M32656 (human), L30114 (5Ј noncoding, baboon), AF052976 (5Ј noncoding, rhesus), M81807 (coding/3Ј noncoding, rhesus); ADH2-M24317 and M32657 (human), M25035 and M59902 (baboon); ADH3-M12272 and M32658 (human), L30113 and L30115 (baboon); mouse (Mus musculus) ADH-M18472. The following sequences were derived in this study: L30114, AFO52976, L30113, and L30115.
Patterns of variation among the aligned sequences were analyzed using compatibility and partition matrices (Sneath, Sackin, and Ambler 1975; Jakobsen and Easteal 1996; Jakobsen, Wilson, and Easteal 1997) with the programs ''reticulate'' and ''partimatrix,'' available at http://jcsmr.anu.edu/dmm/humgen.html.
The compatibility matrix shows the phylogenetic compatibility or incompatibility of all pairs of parsimoniously informative sites arranged in their linear order in the alignment. Two sites in a set of aligned sequences are compatible if a possible evolutionary history of the sequences exists in which all changes at both sites can be inferred to have occurred only once. Incom- Tresize et al. (1991) (and the alignment found at http://jcsmr.anu.edu.au.dmn/humgen.html). The polarity (forward or reverse) of each primer in the PCR is indicated in parentheses in the first column. Numbering of oligonucleotides BAB A and BAB C is according to Stewart et al. (1990). patibility between sites can arise from the multiple occurrence within sites of the same base change in different sequences, or from reticulate evolutionary events, such as recombination or gene conversion, between some of the aligned sequences. Reticulate events are identified by clustering of compatibility and incompatibility among site comparisons, and the matrix is used to identify the regions involved in such events. Clustering of compatible and incompatible sites is evaluated by comparison of neighbor similarity scores (the fraction of adjacent squares in the matrix that are either both compatible or both incompatible) for the observed matrix with the distribution of scores for 1,000 random matrices. The matrices are randomized by shuffling the informative sites. The probability that the observed pattern of compatibility and incompatibility is random is given by the fraction of random matrices that have at least as high a score as the observed matrices.
The partition matrix compares the parsimoniously informative sites for consistency with possible binary partitions of the sequences, i.e., with possible internal branches in the sequence phylogeny. The matrix can be used to detect changes in the support or conflict for particular partitions along the length of the sequence alignment. It can indicate the sequences involved in reticulate events and the timing of such events in relation to sequence divergences.
The phylogenies of sequence regions were investigated using maximum-parsimony methods as implemented in PHYLIP, version 3.5c (Felsenstein 1993) . Substitution rates at synonymous and nonsynonymous sites were estimated by the method of Li (1993) , with correction for multiple substitutions using the two-parameter method of Kimura (1980) . Relative substitution rates were compared by the method of Wu and Li (1985) . NOTE.-Substitution rates are for ϳ310 sites between positions 597 and 908 of the alignment (http://jcsmr.anu.edu.au.dmm/humgen.html) for which sequences are available for all six genes (below the diagonal) and for a longer region (sites 1-908) for which complete sequences are available for all genes except human ADH2 (above the diagonal). 
Results

Cloning and Analysis of cDNA for Baboon Kidney Class I ADH (␥ADH Subunit)
The sequence contains the entire coding region, 72 nucleotides of the 5Ј noncoding region, and 271 nucleotides of the 3Ј noncoding region (data not shown; GenBank accession number L30113). Comparison of the deduced amino acid sequence with other ADHs confirms that this is a class I ADH; thus, the amino acid sequence identities to human class II, III, IV, and V ADHs are 58%, 61%, 68%, and 62%, respectively, but the amino acid sequence identities to ␣, ␤, and ␥ class I ADHs are 74%, 76%, and 80%, respectively. A comparison of the nucleotide sequence for baboon kidney ADH with those previously reported for human ADH class I ␣, ␤, and ␥ subunits (Hempel et al. 1984 (Hempel et al. , 1985 Hoog et al. 1986; von Bahr-Lindstrom et al. 1986 ) and the baboon class I ␤ADH subunit (Trezise et al. 1989 ) reveals a high degree of similarity, and also confirms that this is a class I ADH (tables 2-5). In terms of the deduced protein structure, baboon kidney ADH (␥ADH, see below) has retained all of the zinc-binding residues (active site zinc-Cys/46, His/67, Cys/174; structural zinc-Cys/97, Cys/100, Cys/103, Cys/111), as well as key substrate-binding (Tyr/110, Phe/140, Val/294) and coenzyme interaction (Arg/47, Gly/199, Asp/223, Lys/ 228) residues (see Jornvall et al. 1987; Light et al. 1992) .
The baboon kidney ADH is designated ␥ADH, since it appears from the nucleotide sequence analysis described below to have a more recent common ancestor with the human ␥ADH than with human or monkey ␣-or ␤ADHs. With respect to residues of putative functional importance, the baboon ␥ADH resembles the human ␥ADH in having serine at position 48 in the substrate-binding pocket, instead of the threonine found in the human and monkey ␣-and ␤ADHs. Moreover, both human and baboon ␤-and ␥ADH subunits are distinguished from the ␣ADH subunits at other key residues: Arg (␤-and ␥ADH)/Gly (␣ADH) for position 47; Leu/ Met for position 57; Phe/Ala for position 93; and Leu/ Val for position 116. Baboon ␥ADH also has the same residue (Arg) as the human ␥ 1 ADH at position 271, as compared with the ␥ 2 variant (Gln), but has the human ␥ 2 ADH residue (Val) at position 349, in place of Ile, which is found in human ␥ 1 ADH (Hoog et al. 1986 ). The former residue, 349/Val, is also common in other human and baboon class I ADHs. Of eight nonconservative changes between baboon ␥ADH and all other monkey and ape class I ADH sequences compared (see below), four are shared with other baboon or human ADHs, and none are clearly functionally important residues.
The Pattern of Primate Class I ADH Gene Evolution
In our sequence comparisons, the 5Ј noncoding sequence of the rhesus ADH1 was combined with the previously published coding sequence of the gene. Visual inspection of the compatibility matrix for the three human and three monkey sequences ( fig. 1) indicates different regions of the aligned sequences that are internally compatible but are not compatible with each other. This is confirmed by randomization tests. The observed neighbor similarity score (0.78) was not reached by any of 1,000 random matrices. There is thus evidence that the pattern of evolution of these genes has been reticu- late, probably as a consequence of gene conversion or recombination between different subunit genes. Within the 5Ј noncoding region of the gene (sites 1-908), there is a high degree of overall compatibility among sites (92% of all comparisons are compatible, compared with 77% for the whole matrix). This suggests that this region has a single common phylogenetic history, which contrasts with the coding and 3Ј noncoding regions, in which only 53% of comparisons are compatible and within which the observed neighbor similarity score was lower than those for all 1,000 random matrices. The latter regions are shown at higher resolution in figure 2. The location of the boundary of the 5Ј high-compatibility region cannot be exactly determined, but it is between sites 904 and 929, close to the initiation codon. Visual inspection of this matrix indicates two areas of high internal compatibility 3Ј to this boundary. The first of these, within which 72% of comparisons are compatible, extends from within exon 2 or 3 (between sites 1011 and 1050) to a point within exon 5 (between sites 1332 and 1334). The second, within which 77% of comparisons are compatible, starts near the end of exon 6 (between sites 1667 and 1730) and extends into the 3Ј noncoding region, at least as far as the 3Ј boundary of the alignment. Within these regions, the levels of internal compatibility were exceeded in 2% and 0%, respectively, of 1,000 random matrices for the region of the alignment that encompasses both of them. The levels of compatibility in these regions are also higher than the levels between the regions (39% compatible comparisons). This suggests that the regions have different evolutionary histories.
The proportion of compatible comparisons within the second of the regions is greater than that between this region and the section of the 5Ј noncoding region for which all six sequences are available (sites 597-908; 67%). The proportion of compatible comparisons in the first of the regions is, however, approximately the same as the proportion between this region and the 5Ј noncoding region (72% vs. 71%). Thus, although the two regions appear to have distinct evolutionary histories, only one of their histories is incompatible with the evolutionary history of the 5Ј noncoding region.
There is a further region encompassing parts of exons 5 and 6 (from between sites 1334 and 1339 to between sites 1661 and 1667) within which there is both a relatively low level (51%) and a mosaic pattern of compatibility, suggesting that this region lacks any single strong phylogenetic signal.
The partition matrix ( fig. 3 ) provides further insight into the evolutionary history of the sequences. In the 5Ј noncoding region (sites 597-904), three partitions are strongly supported. These are the partitions that group the human and monkey ADH1 sequences (partition 9), the human and monkey ADH2 sequences (partition 12), and the human and monkey ADH3 sequences (partition 1B). This pattern is confirmed by the maximum-parsimony phylogenetic reconstruction of this region ( fig.  4A ). The use of the mouse sequence as an outgroup indicates that the ADH2 gene was the first to diverge, and that the ADH1 and ADH3 genes are more closely related.
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port for the partition that groups the two ADH2 genes with the human ADH3 gene (partition 16). This pattern is again confirmed by maximum-parsimony phylogenetic reconstruction ( fig. 4B ). The partitions that are most strongly supported in the internally compatible region extending from exon 7 into the 3Ј noncoding region (sites 1730-2299) are 18, 1A, and 1B, which, respectively, group: monkey ADH1 and monkey ADH2; monkey ADH1, monkey ADH2, and human ADH2; and human and monkey ADH3. Once again, these groupings are confirmed by maximum-parsimony phylogenetic reconstruction ( fig. 4C) .
It thus appears that these three regions of the gene have quite different evolutionary histories. The remaining region, encompassing exon 6 and part of exon 5 (sites 1334-1730), does not appear to have any discernible phylogenetic signal. Within this region, which encodes the major part of the coenzyme-binding domain, there is a lower ratio of nonsynonymous to synonymous substitutions than in other regions (fig 5) . Only 2 of 14 informative sites (14%) are nonsynonymous, compared with 25 of 44 (57%) for the rest of the gene. Furthermore, most of the differences at variable sites in the region result from transition substitutions. Synonymous transition substitutions are more likely to occur than other kinds of substitutions, and are therefore more likely to occur independently in different lineages. The relative lack of phylogenetic signal in this region may be a consequence of the fact that in a relatively high proportion of the variable sites, multiple substitutions have occurred in different lineages. It is therefore not possible to determine whether this region has had a different evolutionary history than the adjacent regions or if it shares an evolutionary history with one of them.
The differences in the evolutionary histories of the other three regions presumably arose as a consequence of gene conversion events. The boundaries of these events are uncertain, because two of the regions extend beyond the range of the available sequences, and because of the indeterminate evolutionary history of the exon 5-exon 6 region, which lies between two of them. The polarity of the events and the topology of the original phylogeny can, however, be investigated.
The topologies of the three phylogenies cannot be connected by single gene conversion events. There has to have been at least one intermediate topology. The most parsimonious scheme for connecting the phylogenies is shown in figure 6 . This scheme requires only one intermediate topology ((human ADH3, monkey ADH3), ((human ADH1, monkey ADH1), (human ADH2, monkey ADH2))). All other possible schemes require at least two intermediate topologies. On the basis of the scheme shown in figure 6 , the polarity of the gene conversion events can be determined by considering the lineages in which they must have occurred.
In the exon 2-exon 5 region, the difference between the intermediate topology and the observed topology could have resulted from conversion of the human ADH3 gene by the human ADH2 gene, in which case the intermediate topology would be ancestral to the observed topology. The alternative-that the observed topology was ancestral to the intermediate topologywould imply a xenologous conversion of the human ADH3 gene by the monkey ADH3 gene. Similarly, in the exon 7-3Ј noncoding region, the difference between the intermediate and observed topologies could have resulted from the monkey ADH1 gene being converted by the monkey ADH2 gene. The alternative-that the observed topology was ancestral to the intermediate topology-would again imply a xenologous conversion, this time of the monkey ADH1 gene by the human ADH1 gene. Since horizontal transfer of DNA between the genomes of different primate species is unlikely, it can be assumed that the topologies of the phylogenies observed for the exon 3-exon 5 region and the exon 7-3Ј noncoding region are not the same as the topology of the original phylogeny.
The difference between the topology observed in the 5Ј noncoding region and the intermediate topology could have arisen by conversion of ADH2 by ADH1 or of ADH1 by ADH2 before the human-Old World monkey split, in which case the observed topology would be equivalent to the original topology. Alternatively, it These alternatives can be evaluated by consideration of the nucleotide distances among the sequences in the 5Ј noncoding region and in the coding and 3Ј noncoding regions (tables 2-5). If the topology observed for the 5Ј noncoding region were the original topology, then the distance between ADH1 and ADH2 in the converted region (in this case, the coding and 3Ј noncoding regions) would have been reduced relative to the unconverted region (in this case, the 5Ј noncoding region), whereas the distance between ADH1 and ADH3 would have increased or remained the same depending on the polarity of the conversion.
Alternatively, if the intermediate topology were the original topology and ADH3 had been converted by ADH1, then the distance between ADH1 and ADH3 would have been reduced in the converted region (in this case, the 5Ј noncoding region) relative to the unconverted region (in this case, the coding and 3Ј noncoding regions), whereas the distance between ADH1 and ADH2 would have increased or remained the same, depending on the polarity of the change.
The comparison is complicated by the fact that additional gene conversion events have occurred within the coding and 3Ј noncoding regions. Since the nature of the additional gene conversion events is known, the regions of the topology that have been unaffected by them can be identified, and distance comparisons can be based on these. Thus, estimates of the relative distances between ADH1 and ADH3 and between ADH1 and ADH2 in the intermediate topology can be obtained from the comparison between monkey ADH3 and human ADH1, and between human ADH1 and either human or monkey ADH2, respectively. There is also the possibility that the two regions have intrinsically different substitution rates, in which case both the ADH1-ADH2 and the ADH1-ADH3 distances would differ between the two regions even in the absence of gene conversion. However, both would differ by approximately the same amount. The effect of gene conversion would still potentially be detectable as a difference in the degree to which they differed between the two regions.
It is apparent from the distances above the diagonal in table 5 that for the 3Ј noncoding regions, these ADH1-ADH2 and ADH1-ADH3 distances (ϳ10 and ϳ7 substitutions per site, respectively) are lower than the ADH1-ADH2 and ADH1-ADH3 distances for the 5Ј noncoding region (ϳ16 and ϳ18 substitutions per site, respectively, table 2), which may reflect an intrinsically lower substitution rate. In the coding region (below the diagonal in table 5), the ADH1-ADH2 distance (ϳ10 substitutions per site) is also lower than the equivalent distances in the 5Ј noncoding region. The ADH1-ADH3 distance, however, is approximately the same (ϳ17 substitutions per site), consistent with the 5Ј noncoding region topology being ancestral to the topology of the intermediate phylogeny, with a conversion of ADH2 by ADH1. The comparison of these distances therefore suggests that the basic topology observed for the 5Ј noncoding region is ancestral to the intermediate phylogeny and that it is therefore equivalent to the original phylogeny. The inferred pattern of evolution of these genes is shown in figure 7 . The original gene duplication separated the ADH2 lineage from a lineage ancestral to both ADH1 and ADH3. The timing of this event is discussed below. Subsequently, the ADH1 and ADH3 lineages were separated by a second duplication. Following this, at some time before the ape (including human)-Old World monkey divergence, the coding and 3Ј noncoding regions of the ADH1 gene were converted by the corresponding region of the ADH2 gene. Then, following the ape-Old World monkey split, part of the coding region extending from near the initiation codon to at least within exon 5 of ADH3 was converted by the corresponding region of ADH2 in the ape lineage. In a separate event, also after the ape-Old World monkey split, another part of the coding region of ADH1, extending from some point 5Ј to the start of exon 7 to some point beyond the 3Ј boundary of the alignment, was converted by the corresponding region of ADH2 within the monkey lineage. The order and timing of these conversion events is difficult to determine with accuracy. The se- quence distances in tables 2-5 suggest that both occurred very soon after the ape-Old World monkey split.
Substitution Rate Comparisons
The evolutionary pattern determined above provides a basis for the comparative analysis of substitution rates between lineages. These are made relative to an outgroup reference, and a phylogeny is needed to determine a correct outgroup.
In the 5Ј noncoding region of the gene, there is no evidence of gene conversion, and substitution rates can be compared between genes encoding different subunits and between different species' lineages. The distance matrices between the sequences are shown in table 2. Approximately 800 sites can be compared between five of the sequences, but only ϳ270 sites have been sequenced for the monkey ADH2 gene. No suitable outgroup is available for comparison of the ADH2 substitution rate with that of the other subunit genes, because it was the first to diverge. ADH2 can, however, serve as a reference for comparison of the substitution rates of ADH1 and ADH3. This comparison, using the longer human ADH2 sequence for reference, indicates no difference in substitution rates between the human or Old World monkey ADH1 and ADH3 gene lineages.
The substitution rates of the human and the Old World monkey lineages can be compared between orthologous gene pairs (human ADH1 vs. monkey ADH1, etc). Either human or monkey ADH1 can serve as a reference for the comparison of human and monkey ADH3, and vice versa. Any of the ADH1 or ADH3 genes can serve as a reference for the comparison of human and monkey ADH2 genes. In relative-rate tests, none of these comparisons shows any indication of substitution rate differences between the two lineages (results not shown).
In the coding and 3Ј noncoding regions, separate sequence comparisons must be done for the two regions affected by the gene conversion events. The distance matrices for these two regions are shown in tables 3-5. Relative-rate tests involving all possible valid orthologous and paralogous comparisons were performed, and in no case was evidence found of rate variation between different subunit genes or between human and Old World monkey lineages (results not shown). In both regions, however, the lengths of sequence available for comparison are short; distance estimates are therefore imprecise, and evidence of rate variation is difficult to obtain.
Discussion
Previous attempts to understand the evolutionary history of the primate class I ADH genes (Ikuta et al. 1985; Yokoyama and Yokoyama 1987; Trezise et al. 1989 Trezise et al. , 1991 Yokoyama et al. 1990; Sun and Plapp 1992; Yokoyama and Harry 1993) have not allowed for the possibility of reticulate evolution. Our results clearly show that reticulate evolution has occurred, and that it particularly affects the coding regions of the genes. Since previous studies have been based largely on analysis of coding regions, this may account for discrepancies between the results of these studies and for uncertainties about both branching order and divergence times.
In our analysis, we used a rhesus monkey ADH1 sequence, although we also obtained the 5Ј noncoding region from a baboon. All the other sequences were from baboons. The possibility that this may have confounded the interpretation needs to be considered. Only one of the inferred gene conversion events occurred in the Old World monkey lineage. It is possible that it is restricted to the macaque lineage. However, since the event probably occurred soon after the ape-Old World monkey divergence ( fig. 4C ) and since baboons and macaques are closely related (5Ј sequences confirm this), both being members of the same subfamily (Papioninae) within the same family (Cercopithecidae) of Old World monkeys, this seems unlikely. In any case, the use of the rhesus monkey sequences does not invalidate the conclusion that a gene conversion event of some sort occurred in the Old World monkey lineage. Complete sequences from more species would be needed to determine exactly when and in which lineage it did occur.
The scheme of events depicted in figure 7 implies that ADH1 and ADH3 duplicated subsequent to their joint separation from ADH2, yet Yasunami, Chen, and Yoshida (1990) have described a gene order of ADH1-ADH2-ADH3. Our scheme would therefore imply a duplication resulting in noncontiguous genes.
The distances between the sequences analyzed here provide a basis for some estimation of the timing of the various gene duplication and gene conversion events. Easteal, Collet, and Betty (1995) and Easteal and Herbert (1997) have shown that the noncoding DNA distance between primates and rodents is ϳ6.5 times that between humans and Old World monkeys. For the 5Ј noncoding regions of the ADH genes, the distance between the human ADH2 gene and the ADH1 and ADH3 genes is ϳ4 times that between the human and monkey ADH1 genes and ϳ3 times that between the human and monkey ADH3 genes. It would therefore appear that the primary ADH gene duplication occurred long after the primate-rodent split, although an earlier duplication with subsequent gene conversion cannot be ruled out. Duplication after the primate-rodent split is consistent with the occurrence of a single form of the enzyme (Holmes, Duley, and Burnell 1983; Julia, Ferres, and Pares 1987) , encoded by a single gene (Edenberg et al. 1985; Crabb et al. 1989 ) in mice and rats (Rattus norvegicus) . Uncertainties about the divergence time of apes and Old World monkeys and that of primates from other mammalian orders makes it difficult to estimate the timing of the primary duplication in relation to these events. Southern blot hybridization studies (Yasunami, Chen, and Yoshida 1990) indicate the presence of two genes in rabbits (Oryctolagus cuniculus) and sheep (Ovis aries), as well as horses (Equus caballus), suggesting that the primary duplication may have occurred before the divergence of primates from these other taxa. However, in horses, the two class I ADHs (E and S) are encoded by very similar genes (Pietruszko and Theorell 1969; Park and Plapp 1991) . The two subunits differ at only 10 of 375 residues (or 2.7%), compared with the 20-25 residues that differ among human ␣, ␤, and ␥ subunits, suggesting a relatively recent duplication independent of those that have occurred during the evolution of primates. It is possible that the two genes originated from the same duplication as the primate genes and have subsequently been homogenized by gene conversion. It is also possible, however, that independent gene duplication events have occurred in several mammalian lineages and that the primary duplication of the primate genes occurred subsequent to the divergence of primates from the other mammalian orders. The confinement of gene conversion events largely to the coding regions of the genes may be a consequence of a number of factors, including (1) the slower rate of divergence and, hence, the greater degree of similarity of the coding sequences; (2) the possible role in gene conversion of reverse transcription from an mRNA intermediate; and (3) natural selection favoring new combinations of different parts of the coding regions. It is not possible to distinguish between these alternatives from the present data.
There has long been controversy over whether substitution rates vary among simian primate lineages (Easteal, Collet, and Betty 1995, pp. 43-64) . For nuclear DNA, there is no indication of general rate differences among apes (including humans), or between apes and New World monkeys. Results have, however, been interpreted as showing a slower rate of substitution for the human lineage than for the Old World monkey lineage (Li, Tanimura, and Sharp 1987; Bailey et al. 1991; Seino, Bell, and Li 1992; Ellsworth, Hewett-Emmett, and Li 1993; Li et al. 1996) . This is inconsistent with the results of DNA-DNA hybridization experiments (Benveniste 1985) , which indicate that substitution rates for the two lineages are the same. Easteal (1991) and Herbert and Easteal (1996) have shown that for many genes, the substitution rates are the same, and they, Easteal, Collet, and Betty (1995, pp. 43-64) , and Easteal and Herbert (1997) have argued that the regions of the genome at which rates vary are exceptions to the general rule of rate uniformity. Our results provide no evidence of rate variation between the lineages. In the coding and 3Ј noncoding regions, this may be due to the short lengths of the regions being compared. In the 5Ј noncoding region, there is no evidence of any rate difference in three independent comparisons of approximately 800 sites. This gives further support to the view that, in general, substitution rates in the nuclear genome are uniform between these two lineages. Since the rates appear to be uniform among other simian primate lineages, this is consistent with there being general rate uniformity among simian primates.
Sites of known functional significance tend to be conserved, and sequence variation at such sites is of particular interest, as it may provide a causal explanation for correlated functional variation. The only known substantial kinetic differences between ␥ADH and the other class I homodimers is with respect to substrate inhibition at relatively high ethanol concentrations (Bosron and Li 1986) . This is unlikely to represent an adaptive explanation for lack of this isozyme in the baboon liver and expression in the kidney. Futhermore, sequence variations in baboon ␥ADH compared with any one of the other five sequences are not apparently in functionally significant residues, and so are unlikely to contribute to a key functional difference between the human and baboon kidney isozymes.
In the 5Ј noncoding region, a number of cis-acting transcriptional regulatory sequences have been identified in human class I ADH genes to which nuclear proteins or purified activators bind (Carr and Edenberg 1990; Stewart et al. 1990 Stewart et al. , 1991 Edenberg and Brown 1992) . These include C/EBP␣, Sp1, USF, HNF1, CTF/NF1, the glucocorticoid receptor, and RAR␣.
Binding studies (Stewart et al. 1990; Edenberg and Brown 1992 ) using purified C/EBP␣ identified two sites of strong binding in all three human promoters on either side of the TATA box. The binding affinity was much higher with the ADH2 gene than with the ADH1 and ADH3 genes. Comparison of these two regions with those for the baboon ADH genes and the C/EBP␣ consensus palindrome shows that there are only three sites (sites 7, 8, and 9 in the upper two comparisons in fig.  8 ) that are entirely conserved across both regions. These sites are adjacent and have the same motif (CAA) as the C/EBP␣ consensus. Among the variable sites, site 6 is of particular interest. It is the least variable and the most like the C/EBP␣ consensus-all sequences have the C/ EBP␣ consensus ''G'' at this site except two (monkey ADH1 and monkey ADH3), which both have ''A.'' Furthermore, this is the only site at which the pattern of variation is inconsistent with the sequence phylogeny, indicating that substitution of G by A occurred independently in the monkey ADH1 and ADH3 lineages. This difference could be the cause of the differential binding affinity between ADH2 and ADH1/ADH3 in monkeys, and since it has arisen independently in the two lineages, it is particularly worthy of further investigation as a contributory cause of the absence of expression of ADH1 and ADH3 in the baboon liver. It is unlikely to be the sole reason, however, since ADH1 is expressed in the rhesus liver (Light et al. 1992) which also has an A at this site; a possible additional factor is the spacing between the two sites, which is one nucleotide longer in rhesus ADH1.
Farther upstream of these two sites are two more sites which bind C/EBP weakly but are important for basal level activity and/or activation by C/EBP (Stewart et al. 1991) . Comparison of these two regions (lower two comparisons, fig. 8 ) with the baboon promoters and the C/EBP palindrome showed that of the three sites (7, 8, and 9) conserved across all sequences in the other two regions, two (7 and 8) have the same CA motif across all sequences in these regions, suggesting that they are important for binding. The third site has the same C/EBP␣ consensus base, A, in all sequences except baboon ADH3. The role of this difference in determining the expression pattern of ␥ADH is worth further investigation.
The transcription-activating factor, Sp1 (Kadonaga, Jones, and Tijan 1986) , binds with high affinity to the G3T site (shown in fig. 9 ) of human ADH2, but with lower affinity to the G3T sites of human ADH1 and ADH3 (Brown, Baltz, and Edenberg 1992) . All but three of the 11 positions (positions 1, 2, and 8 in fig. 9 ) of the G3T site are entirely conserved across all six sequences. It has been proposed that the sequence differences between ADH2 and ADH1 and ADH3 at sites 1 and 2 might explain the relatively lower binding affinity of ADH1 and ADH3 (Brown, Baltz, and Edenberg 1992) . The distribution of variation among all six sequences indicates that the ancestral state of site 1 was A, and that the G in human ADH2 is derived. If this variation is associated with the difference in binding affinity, it would imply that weak affinity was the ancestral condition, with stronger binding affinity being acquired secondarily in ADH2. Similarly, at site 2, the distribution of variation across all six sequences implies that the ancestral state was T, and that the C in human ADH3 is derived. The absence of C in human ADH1 implies that it is not necessary for weak binding, although it may contribute.
The only other variation among the sequences is a T→C change in baboon ADH3 at nucleotide 735 (site 8 in fig. 9 ). The possibility that this change, together with a lower binding affinity, contributes to the absence of ␥ADH from baboon liver needs further investigation.
Our analysis, as in other systems (e.g., Tagle et al. 1988) , has made it possible for several predictions to be made about the relative importance of specific nucleotide sequence differences to patterns of ADH expression (see also Tagle et al. 1988; Pajovic et al. 1994) . Experiments involving expression in cell lines and site-directed mutagenesis are necessary to test these predic-tions. The patterns of class I ADH expression are very different in humans and baboons, and it is likely that these differences are adaptive. Identifying the specific sequence changes that have caused the differences in expression will provide an understanding of the molecular basis of this form of adaptive evolution.
